Intuitive Earnings: US Procedures Slow, Extended Use Program's Benefit Offsets Near-Term Impact
Intuitive Surgical reported strong platform placements in the third quarter, but US sales growth decelerated.
Intuitive Surgical Inc ISRG
Bulls Say, Bears Say
Bulls
Uptake of Intuitive's next-generation platform has been strong, giving significant momentum to system placements in the next few years.
Bears
We may be seeing the emergence of some competition, particularly for lower-cost procedures. Competition, in the form of refurbished tools, is also going after instrumentation.
News
Intuitive Surgical Up Over 7%, on Pace for Largest Percent Increase Since October 2025 — Data Talk
Intuitive Appoints Aaron Martin to its Board of Directors
7 healthcare stocks that stand out as investors pay up for the sector
7 healthcare stocks that stand out as -2-
Stocks to Watch: SpaceX, Tesla, Netflix, Super Micro Computer, Intuitive Surgical
Intuitive Surgical 3Q Earnings Hurt by Charge Despite Higher Revenue
Intuitive Announces Third Quarter Earnings
New meta-analysis shows statistically significant improvements in patient outcomes associated with da Vinci surgery versus laparoscopic and open surgery across 13 common benign conditions
Trading Information
- Previous Close Price
- $452.80
- Day Range
- $454.04–463.00
- 52-Week Range
- $328.57–603.88
- Bid/Ask
- $459.00 / $461.99
- Shares Outstanding
- 346.64M
- Market Cap
- $162.71B
- Volume/Avg
- 4,221 / 2M
Key Statistics
- Price/Earnings (Normalized)
- 42.53
- Price/Sales
- 14.21
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- 2.89%
Company Profile
Intuitive develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed more than 11,000 da Vinci systems in hospitals worldwide, with more than 6,600 installations in the US and a growing number in emerging markets.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Stock Style Box
- Large Core
- Total Number of Employees
- 17,021
- Website
- https://www.intuitive.com
Competitors
Valuation
Metric | ISRG | MDT | SYK |
|---|---|---|---|
Price/Earnings (Normalized) | 42.53 | 18.16 | 22.81 |
Price/Book Value | 9.99 | 2.62 | 5.29 |
Price/Sales | 14.21 | 3.53 | 4.78 |
Price/Cash Flow | 33.78 | 14.75 | 23.40 |
Price/Earnings
ISRG
MDT
SYK
Financial Strength
Metric | ISRG | MDT | SYK |
|---|---|---|---|
Quick Ratio | 2.32 | 1.29 | 1.07 |
Current Ratio | 3.33 | 2.07 | 2.18 |
Interest Coverage | — | 10.12 | 9.73 |
Quick Ratio
ISRG
MDT
SYK
Profitability
Metric | ISRG | MDT | SYK |
|---|---|---|---|
Return on Assets (Normalized) | 19.33% | 8.31% | 11.66% |
Return on Equity (Normalized) | 22.41% | 15.59% | 24.04% |
Return on Invested Capital (Normalized) | 20.67% | 10.57% | 15.46% |
Return on Assets
ISRG
MDT
SYK
Medical Instruments & Supplies Industry Comparables
1-Day Chart | Name | Price | Morningstar Rating for Stocks | Capital Allocation | Economic Moat | Market Cap |
|---|---|---|---|---|---|---|
| Becton Dickinson & Co BDX | LOCK|%X | LOCK|@@#K | $59B | |||
| Alcon Inc ALC | LOCK|x!Lm>Y | LOCK|K!@B | $36B | |||
| Medline Inc Ordinary Shares - Class A MDLN | LOCK|&V&p^< | LOCK|y#<cJ | $36B | |||
| ResMed Inc RMD | LOCK|HgPg?!! | LOCK|fZ#?g | $33B | |||
| West Pharmaceutical Services Inc WST | LOCK|h@<y$$> | LOCK|@V% | $29B | |||
| Solventum Corp SOLV | LOCK|mdgh%s | LOCK|fd | $15B | |||
| Baxter International Inc BAX | LOCK|&<M | LOCK|@c?&V | $14B | |||
| Align Technology Inc ALGN | LOCK|Z>&^KQM | LOCK|y!cSd | $12B | |||
| The Cooper Companies Inc COO | LOCK|yTQwhd# | LOCK|J%@T | $12B |
United States